United States · FDA National Drug Code directory
LUCENTIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-080_71a6df7b-906b-4de9-ad4f-200285958cdc
- Product NDC
- 50242-080
- Form
- INJECTION, SOLUTION
- Composition / generic term
- RANIBIZUMAB
- Labeler
- Genentech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20060630
- Source listing expiry
- 20261231
Source-listed ingredients
- RANIBIZUMAB — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (50242-080-03) / .05 mL in 1 SYRINGE, GLASS · 50242-080-03
- 1 SYRINGE, GLASS in 1 CARTON (50242-080-88) / .05 mL in 1 SYRINGE, GLASS · 50242-080-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →